at Investor's Business Daily (Thu, 11:02AM)
An FDA panel recommends approval of J&J's (JNJ) psoriasis treatment, even though more data...
An FDA panel recommends approval of J&J's (JNJ) psoriasis treatment, even though more data is needed to determine its cancer risks.
From other sites
at Investor's Business Daily (Tue, 11:20AM)
at Zacks.com (Tue, 9:00AM)
at CNBC.com (Tue, 8:50AM)
Pre-Market Earnings Report for January 20, 2015 : JNJ, MS, DAL, HAL, BHI, MTB, RF, IGTE, ATI, EDU, MTG, SAPat Nasdaq.com (Jan 16, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs